# Evaluation of the Aurora Xi New Nomogram Software 2.0

> **NCT06122935** · NA · COMPLETED · sponsor: **Fenwal, Inc.** · enrollment: 6735 (actual)

## Conditions studied

- Apheresis Related Hypotension

## Interventions

- **DEVICE:** Aurora Xi New Nomogram Software 2.0
- **DEVICE:** Aurora Xi Currently Approved Software 1.3

## Key facts

- **NCT ID:** NCT06122935
- **Lead sponsor:** Fenwal, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-27
- **Primary completion:** 2024-04-19
- **Final completion:** 2024-05-31
- **Target enrollment:** 6735 (ACTUAL)
- **Last updated:** 2025-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06122935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06122935, "Evaluation of the Aurora Xi New Nomogram Software 2.0". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT06122935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*